Cervical Radiculopathy
Conditions
Interventions
Patient Group:Meridian manipulation
Patient Group:Rotation-Traction Manipulation
Health Group:None
Sponsors
China Academy of Chinese Medical Sciences Wangjing Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Intervention Group (1) Meet the aforementioned diagnostic criteria for CSR; (2) Aged 18 to 60 years; (3) Present with unilateral neck and shoulder pain, accompanied by radiating numbness and pain in the upper limb; (4) Right-handed with no cognitive impairment; (5) Voluntarily sign the informed consent form. Control Group (1) Aged 18 to 60 years; (2) No obvious symptoms of neck discomfort, and confirmed by an outpatient physician to have no significant cervical diseases; (3) Cervical radiographs (X-rays) clearly confirm the absence of changes such as "cervical degeneration" or "intervertebral foraminal narrowing" (foraminal stenosis); (4) Right-handed with no cognitive impairment; (5) Voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: Intervention Group (1) Cervical spondylotic myelopathy (CSM); undiagnosed spinal injuries, or symptoms of spinal cord injury; (2) Spinal cord lesions such as amyotrophic lateral sclerosis (ALS); space-occupying lesions of the cervical nerves such as schwannoma; or intracranial lesions causing upper limb numbness and weakness; (3) History of cervical spine surgery or cervical spine deformity; developmental cervical spinal stenosis (canal-to-body ratio = sagittal diameter of the spinal canal / sagittal diameter of the vertebral body < 0.75); (4) Severe cardiovascular, pulmonary, cerebrovascular, hepatic, renal, or hematopoietic diseases; (5) Osteoarticular tuberculosis, osteomyelitis, osteoporosis, and related conditions; (6) Women who are pregnant, planning to become pregnant, or lactating; (7) Unable to complete the clinical study due to psychiatric disorders, cognitive impairment, or emotional disorders; (8) Skin diseases or skin lesions at the sites of electromyography (EMG) and electroencephalography (EEG) electrode placement; (9) Participation in other clinical trials within the past 3 months. Control Group (1) Severe cardiovascular, pulmonary, cerebrovascular, hepatic, renal, or hematopoietic diseases; (2) Skin diseases or skin lesions at the sites of EMG and EEG electrode placement; (3) Women who are pregnant, planning to become pregnant, or lactating; (4) Unable to complete the clinical study due to psychiatric disorders, cognitive impairment, or emotional disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Neck Disability Index;PSD;COH;PLV;PLI;wPLI;SampEn;ApEn;PeEn;LZC;HFD;RMS;iEMG;MDF;MNF; | — |
Countries
China
Contacts
Public ContactFeng Min Shan
China Academy of Chinese Medical Sciences Wangjing Hospital
Outcome results
None listed